Home R&D Page 4

R&D

Phase 2a clinical study on Molgradex for the treatment of NTM...

Encouraging results for bispecific antibody in macular diabetic edema

First bispecific monoclonal antibody approved to treat hemophilia A with inhibitors

Somatic cell therapy product to treat complex anal fistulas in Crohn’s...

A 3D bioprinting facility at Trinity College Dublin

A partnership for ultra-rare disease APECED/APS-1

Looking for extractables and leachables

Negative opinion for anamorelin hydrochloride

Results from EMBRACA Phase 3 trial in breast cancer

Erenumab to prevent migraine: results from phase III STRIBE

1...345...16Page 4 of 16
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151